ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 570,20
-0,77%
Dow Jones
38 834,86
0,15%
DAX
18 067,91
-0,31%
Brent Oil
84,695
-0,11%
Bitcoin
64 910,57
-0,35%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. PainReform Ltd (PRFX)

  7. PainReform Ltd (PRFX) Actualités

PRFX PainReform Ltd

0,4966
-0,0024 (-0,48%)
19 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
PainReform Ltd PRFX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,0024 -0,48% 0,4966 01:55:52
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,494 0,4677 0,51485 0,491 0,499
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
31/5/202422:24EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/5/202422:15GLOBEPainReform Announces Receipt of Nasdaq Minimum Bid Price..
15/5/202422:05GLOBEPainReform Provides Business Update for the First Quarter of..
08/5/202414:30GLOBEPainReform CEO Ilan Hadar Discusses Latest Developments..
18/4/202420:19GLOBEPainReform Announces Closing of $4 Million Public Offering
16/4/202414:00GLOBEPainReform Announces Pricing of $4 Million Public Offering
09/4/202415:00GLOBEPainReform’s Non-Opiate Topical Treatment for Post-Surgical..
02/4/202414:30GLOBEPainReform Reaches 50% Enrollment in the Second Part of its..
07/3/202423:25EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/3/202422:34EDGAR2Form F-1 - Registration statement for certain foreign..
01/3/202414:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/3/202414:00GLOBEPainReform Provides Year-End Business Update
29/2/202422:37EDGAR2Form 20-F - Annual and transition report of foreign private..
22/1/202414:30GLOBEPainReform to Present at the Microcap Conference in Atlantic..
22/1/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
19/1/202422:30EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
12/1/202422:15EDGAR2Form F-3 - Registration statement by foreign private issuers
03/1/202414:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/1/202414:30GLOBEPainReform Reports Successful Head-to-Head Comparison of..
27/12/202322:04EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
27/12/202322:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/12/202300:00GLOBEPainReform Announces Exercise of Warrants for Approximately..
15/11/202322:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/11/202322:05GLOBEPainReform Provides Business Update for the Third Quarter of..
11/9/202314:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/9/202314:30GLOBEPainReform Announces Plans to Commence Second Part of Phase..
07/9/202316:00GLOBEPainReform Selected for Poster Presentation at the 13th..
05/9/202322:16EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
05/9/202314:30GLOBEPainReform to Participate in the H.C. Wainwright 25th Annual..
25/8/202322:15EDGAR2Form F-1 - Registration statement for certain foreign..
10/8/202322:18EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/8/202322:05GLOBEPainReform Provides Business Update for the Second Quarter..
19/7/202315:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/7/202315:00GLOBEPainReform Regains Compliance with Nasdaq Continued Listing..
18/7/202317:59EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
18/7/202317:57EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/7/202321:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/7/202320:35GLOBEPainReform Announces Pricing of $1.5 Million Concurrent..
14/7/202318:26EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/7/202318:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/7/202315:23EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/7/202315:05GLOBEPainReform Announces Pricing of $2.7 Million Concurrent..
29/6/202322:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Dernières Valeurs Consultées

NASDAQ
PRFX
PainReform
AMEX
RVRS
Reverse Cap Weighted US ...
USOTC
HDIUF
Adentra (PK)
TG
3YB
Postal Savings Bank of C...
TSX
PMN
ProMIS Neurosciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés